Informing on health and wellness news in Bulgaria
Provided by AGP
AGP Picks
View all
Perspectify News
Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
Filter
Press releases
Publish your press release
May. 4, 2026
Annual Report 2025
ECB - European Central Bank
In 2025 the ECB succeeded in bringing inflation back in line with its medium-term target of 2%, after a succession of crises – the pandemic, the economic fallout of Russia’s unjustified invasion of Ukraine – had driven it to record highs in late...
Apr. 14, 2026
Er-Kim Signs Exclusive Distribution Agreement with LEO Pharma A/S to Commercialize LOQTORZI® (toripalimab) for Nasopharyngeal and Oesophageal Cancers
GlobeNewswire, Inc.
ISTANBUL and BALLERUP, Denmark, April 14, 2026 (GLOBE NEWSWIRE) -- Er-Kim, an international pharmaceutical company specializing in the commercialization of novel therapies in the EMEA region, today announced that it has signed an exclusive...
Apr. 1, 2026
AskBio Announces Completion of Enrollment in Phase 2 Clinical Trial of AB-1002 Investigational Gene Therapy for Heart Failure
GlobeNewswire, Inc.
Durham, N.C., April 01, 2026 (GLOBE NEWSWIRE) -- Final participant randomized in the GenePHIT Phase 2 clinical trial assessing safety and efficacy of AB-1002 for adults with non-ischemic cardiomyopathy and New York Heart Association (NYHA) Class...
Mar. 18, 2026
Er-Kim Leads Pharma & Cosmetics Sector; Places #6 Overall in Bulgaria’s Premier Business Ranking
EIN Presswire
Capital’s Cheetah ranking recognizes the rapidly growing and most resilient SMEs in Bulgaria’s economy SOPHIA, SOPHIA, BULGARIA, March 18, 2026 /EINPresswire.com/ -- Er-Kim, an international pharmaceutical company specializing in the...
Mar. 16, 2026
Elevara Medicines Doses First Patient in Phase 2b START-SYNERGY Trial of ELV001 in Rheumatoid Arthritis Patients with Incomplete Response to TNFi
GlobeNewswire, Inc.
ELV001 aiming to disrupt the treatment paradigm for patients with incomplete response to standard of care (methotrexate + TNF inhibitors) Phase 2b trial enrolling approximately 180 patients across nine countries Primary endpoint: change in...
Mar. 3, 2026
To Her Excellency Ms. Iliana Iotova, President of the Republic of Bulgaria
President of Azerbaijan
AZERBAIJAN, March 3 - 03 March 2026, 11:09 Dear Madam President, I cordially congratulate you and your people on the occasion of the national holiday of the Republic of Bulgaria.
Video Stories
Sign up for Wellness Daily Bulgaria.
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.
Explore More
